ARCHIVES

Senate Confirms McClellan For FDA

This article is from The Cancer Letter archive.

Vol. 28 No. 39 | October 25, 2002

Download PDF Visit The Full Archive

Related Articles

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

Group Chairmen Accept Most Changes In Terms Of Award, Object To CTEP Adjustments

December 2, 1988

More Radiation Increases Prostate Cancer Response

August 30, 2002

In Brief: alberts elected To Second Term as NAS President

February 19, 1999

NTP Committee Accepts Industry Positions On Policy To Separate Figures for Benign, Malignant Lesions

November 7, 1980

HHS Appeals Board Finds No Misconduct By Popovic

November 12, 1993